APOL3 and Alzheimer disease: LAMC1, MYO1C, LRP10, and NDNF expression showed a significant positive correlation with AD progression in both men and women, TMOD3 showed a significant positive correlation with AD progression in men, and APOL3 showed a significant positive correlation with AD progression in females (Figure 4B).